Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
BUSULFAN + MELPHALAN WAS ASSOCIATED WITH A LONGER PFS COMPARED TO MELPHALAN ALONE IN HIGH-RISK MULTIPLE MYELOMA IN A RANDOMIZED PHASE 3 CLINICAL TRIAL
13 októbra, 2020 5:56 pmAuthor(s): Muzaffar Qazilbash, Qaiser Bashir, Peter Thall, et al. Abstract: S124 Session topic: 23. Stem cell transplantation –...
LENALIDOMIDE-PREDNISONE VS LENALIDOMIDE ALONE MAINTENANCE IN NEWLY DIAGNOSED MULTIPLE MYELOMA: INDIVIDUAL PATIENT DATA META-ANALYSIS OF 2 RANDOMIZED PHASE III TRIALS
13 októbra, 2020 5:56 pmAuthor(s): Francesca Gay, Lorenzo De Paoli, Alessandra Larocca Abstract: PS1299 Session topic: 14. Myeloma and other monoclonal gammopathies...
CONSOLIDATION FOLLOWED BY MAINTENANCE VS MAINTENANCE ALONE IN NEWLY DIAGNOSED, TRANSPLANT ELIGIBLE MULTIPLE MYELOMA: A RANDOMIZED PHASE 3 STUDY OF THE EUROPEAN MYELOMA NETWORK (EMN02/HO95 MM TRIAL)
13 októbra, 2020 5:56 pmAuthor(s): P Sonneveld, M Beksac, B vanderHolt, et al. Abstract: S108 Session topic: 14. Myeloma and other monoclonal...
A TRIPLET BORTEZOMIB- AND IMMUNOMODULATOR-BASED THERAPY BEFORE AND AFTER DOUBLE ASCT IMPROVES OVERALL SURVIVAL OF NEWLY DIAGNOSED MM PATIENTS: FINAL ANALYSIS OF PHASE 3 GIMEMA-MMY-3006 STUDY
13 októbra, 2020 5:56 pmAuthor(s): Paola Tacchetti, Francesca Patriarca, Maria Teresa Petrucci, et al. Abstract: S105 Session topic: 14. Myeloma and other...
MNOHOPOČETNÝ MYELÓM Novinky z kongresu
13 októbra, 2020 5:56 pmMnohopočetný myelóm (MM) je veľmi heterogénne ochorenie, či už klinicky, biologicky alebo geneticky. Toto ochorenie však patrí v súčasnosti medzi hematologické...
PROGNOSTIC IMPACT OF ASXL1 MUTATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND MULTILINEAGE DYSPLASIA WITH OR WITHOUT RING SIDEROBLASTS
13 októbra, 2020 5:56 pmAuthor(s): Abhishek Mangaonkar, Terra Lasho, Christy Finke, et al. Abstract: PF501 Session topic: 10. Myelodysplastic syndromes – Clinical...
INTENSIVE CHEMOTHERAPY (IC) IS MORE EFFECTIVE THAN HYPOMETHYLATING AGENTS (HMA) FOR THE TREATMENT OF YOUNGER PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) AND ELEVATED BONE MARROW BLASTS
13 októbra, 2020 5:56 pmAuthor(s): Paolo Strati, Guillermo Garcia-Manero, Tapan Kadia, et al. Abstract: PS1251 Session topic: 10. Myelodysplastic syndromes – Clinical...
DESCRIPTION OF MUTATIONAL PROFILE IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES AT THE TIME OF LEUKEMIC PROGRESSION
13 októbra, 2020 5:56 pmAuthor(s): Begoña Pedrote, Jose Francisco Falantes, Estrella Carrillo, et al. Abstract: PF496 Session topic: 10. Myelodysplastic syndromes –...
SEVERE THROMBOCYTOPENIA AS A PREDICTOR OF SURVIVAL AND RESPONSE TO HYPOMETHYLATING AGENTS: DATA FROM A LATIN-AMERICAN COHORT
13 októbra, 2020 5:56 pmAuthor(s): Carolina Lazzarino, Marcelo Iastrebner, Jacqueline Gonzalez, et al. Abstract: PS1259 Session topic: 10. Myelodysplastic syndromes – Clinical...
MYELODYSPLASTICKÝ SYNDROM – VÝBĚR Z EDUKAČNÍCH SDĚLENÍ A POSTERŮ
13 októbra, 2020 5:56 pmPráce publikované formou edukačních sdělení 1. FACING THE CHALLENGE: NOVEL TREATMENT OPTIONS FOR PATIENTS WITH MYELODYSPLASTIC SYNDROMES Nové...